270 related articles for article (PubMed ID: 31677389)
1. The Macrophage Activation Marker Soluble CD163 is Longitudinally Associated With Insulin Sensitivity and β-cell Function.
Semnani-Azad Z; Connelly PW; Johnston LW; Retnakaran R; Harris SB; Zinman B; Hanley AJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):e285-94. PubMed ID: 31677389
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.
Deichgræber P; Witte DR; Møller HJ; Skriver MV; Richelsen B; Jørgensen ME; Johansen NB; Sandbæk A
Diabetologia; 2016 Nov; 59(11):2467-2476. PubMed ID: 27541014
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD163: a biomarker linking macrophages and insulin resistance.
Parkner T; Sørensen LP; Nielsen AR; Fischer CP; Bibby BM; Nielsen S; Pedersen BK; Møller HJ
Diabetologia; 2012 Jun; 55(6):1856-62. PubMed ID: 22450890
[TBL] [Abstract][Full Text] [Related]
4. Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.
Zanni MV; Burdo TH; Makimura H; Williams KC; Grinspoon SK
Clin Endocrinol (Oxf); 2012 Sep; 77(3):385-90. PubMed ID: 22098563
[TBL] [Abstract][Full Text] [Related]
5. The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss.
Fjeldborg K; Christiansen T; Bennetzen M; J Møller H; Pedersen SB; Richelsen B
Obesity (Silver Spring); 2013 Dec; 21(12):2437-43. PubMed ID: 23512476
[TBL] [Abstract][Full Text] [Related]
6. Adipose Tissue Insulin Resistance Is Longitudinally Associated With Adipose Tissue Dysfunction, Circulating Lipids, and Dysglycemia: The PROMISE Cohort.
Semnani-Azad Z; Connelly PW; Bazinet RP; Retnakaran R; Jenkins DJA; Harris SB; Zinman B; Hanley AJ
Diabetes Care; 2021 Jul; 44(7):1682-1691. PubMed ID: 34001534
[TBL] [Abstract][Full Text] [Related]
7. Changes in adiposity mediate the associations of diet quality with insulin sensitivity and beta-cell function.
Lai KZH; Semnani-Azad Z; Retnakaran R; Harris SB; Hanley AJ
Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3054-3063. PubMed ID: 34518089
[TBL] [Abstract][Full Text] [Related]
8. The Association between Monocyte Surface CD163 and Insulin Resistance in Patients with Type 2 Diabetes.
Kawarabayashi R; Motoyama K; Nakamura M; Yamazaki Y; Morioka T; Mori K; Fukumoto S; Imanishi Y; Shioi A; Shoji T; Emoto M; Inaba M
J Diabetes Res; 2017; 2017():6549242. PubMed ID: 29445750
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
Laursen TL; Wong GL; Kazankov K; Sandahl T; Møller HJ; Hamilton-Dutoit S; George J; Chan HL; Grønbaek H
J Gastroenterol Hepatol; 2018 Feb; 33(2):484-491. PubMed ID: 28618015
[TBL] [Abstract][Full Text] [Related]
11. The macrophage activation product sCD163 is associated with a less favourable metabolic profile in prepubertal children.
Carreras-Badosa G; Prats-Puig A; Diaz-Roldan F; Platero-Gutierrez E; Osiniri I; Riera-Perez E; de Zegher F; Ibañez L; Bassols J; López-Bermejo A
Pediatr Obes; 2016 Dec; 11(6):543-550. PubMed ID: 26843034
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction.
Kračmerová J; Rossmeislová L; Kováčová Z; Klimčáková E; Polák J; Tencerová M; Mališová L; Štich V; Langin D; Šiklová M
J Clin Endocrinol Metab; 2014 Mar; 99(3):E528-35. PubMed ID: 24423341
[TBL] [Abstract][Full Text] [Related]
13. Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.
Reid M; Ma Y; Scherzer R; Price JC; French AL; Plankey MW; Grunfeld C; Tien PC
AIDS; 2017 Jan; 31(3):385-393. PubMed ID: 28081037
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble CD163 predicts risk of type 2 diabetes in the general population.
Møller HJ; Frikke-Schmidt R; Moestrup SK; Nordestgaard BG; Tybjærg-Hansen A
Clin Chem; 2011 Feb; 57(2):291-7. PubMed ID: 21106861
[TBL] [Abstract][Full Text] [Related]
15. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
[TBL] [Abstract][Full Text] [Related]
17. Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.
Rødgaard-Hansen S; St George A; Kazankov K; Bauman A; George J; Grønbæk H; Jon Møller H
Scand J Clin Lab Invest; 2017 Nov; 77(7):498-504. PubMed ID: 28715286
[TBL] [Abstract][Full Text] [Related]
18. Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort.
Johnston LW; Harris SB; Retnakaran R; Giacca A; Liu Z; Bazinet RP; Hanley AJ
Diabetologia; 2018 Apr; 61(4):821-830. PubMed ID: 29275428
[TBL] [Abstract][Full Text] [Related]
19. An alternatively activated macrophage marker CD163 in severely obese patients: the influence of very low-calorie diet and bariatric surgery.
Cinkajzlová A; Lacinová Z; Kloučková J; Kaválková P; Trachta P; Kosák M; Krátký J; Kasalický M; DoleŽalová K; Mráz M; Haluzík M
Physiol Res; 2017 Sep; 66(4):641-652. PubMed ID: 28406702
[TBL] [Abstract][Full Text] [Related]
20. The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.
Kazankov K; Barrera F; Møller HJ; Rosso C; Bugianesi E; David E; Younes R; Esmaili S; Eslam M; McLeod D; Bibby BM; Vilstrup H; George J; Grønbaek H
Liver Int; 2016 Oct; 36(10):1549-57. PubMed ID: 27102725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
